share_log
Reuters ·  Dec 30, 2024 16:16
Sangamo Therapeutics Inc: Collaboration and License Agreement With Pfizer Will Terminate Effective April 21, 2025
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment